Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial.

J Diabetes Investig · 2013 · PMC4020256 · PMID 24843715

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP = 0.05actually significant

A lower mean rate of nocturnal confirmed hypoglycemia was also observed for IDeg relative to IGlar in the maintenance period, but this did not reach statistical significance (RR 0.52 [95% CI 0.27 to 1.00] P = 0.05).

also in 75,868 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.